Literature DB >> 14330030

DANGEROUS EFFECTS OF ISOPRENALINE IN MYOCARDIAL FAILURE.

M F LOCKETT.   

Abstract

Entities:  

Keywords:  BLOOD PRESSURE; CATS; EXPERIMENTAL LAB STUDY; HEART; HEART FAILURE, CONGESTIVE; HEART RATE; ISOPROTERENOL; METABOLISM; ORCIPRENALINE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1965        PMID： 14330030     DOI： 10.1016/s0140-6736(65)92221-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

1.  A novel catecholamine, arbutamine, for a pharmacological cardiac stress agent.

Authors:  R Nagarajan; G Abou-Mohamed; T Myers; R W Caldwell
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

2.  Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing.

Authors:  G Abou-Mohamed; R Nagarajan; T M Ibrahim; R W Caldwell
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

3.  A comparison of the actions of different bronchodilators in asthma.

Authors:  B J Freedman; P Meisner; G B Hill
Journal:  Thorax       Date:  1968-11       Impact factor: 9.139

4.  Management of status asthmaticus.

Authors:  H A Rees
Journal:  Postgrad Med J       Date:  1967-04       Impact factor: 2.401

5.  Asthma deaths: a question answered.

Authors: 
Journal:  Br Med J       Date:  1972-11-25

6.  Mortality from asthma.

Authors:  M K McAllen
Journal:  J R Coll Gen Pract       Date:  1969-04

Review 7.  Heart transplantation: approaching a new century.

Authors:  B Radovancević; O H Frazier
Journal:  Tex Heart Inst J       Date:  1999

Review 8.  Asthma and the beta agonist debate.

Authors:  J Crane; N Pearce; C Burgess; R Beasley
Journal:  Thorax       Date:  1995-09       Impact factor: 9.139

9.  Isoprenaline-induced changes in regional myocardial perfusion in the pathogenesis of myocardial necrosis.

Authors:  P Collins; C G Billings
Journal:  Br J Exp Pathol       Date:  1976-12

Review 10.  Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.

Authors:  Shelley R Salpeter
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.